What is Kimberly Tamargo's NPI number?

Kimberly Tamargo's National Provider Identifier (NPI) is 1003336140, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Kimberly Tamargo's specialty?

Kimberly Tamargo is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Kimberly Tamargo located?

Kimberly Tamargo's practice location on file with NPPES is 3624 W Market St Ste 101, Fairlawn, OH 44333-4510.

What is Kimberly Tamargo's phone number?

The practice phone number listed in the NPPES registry for Kimberly Tamargo is (330) 665-0555.

Does Kimberly Tamargo accept Medicare?

Kimberly Tamargo is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Kimberly Tamargo's NPI active?

Yes — Kimberly Tamargo's NPI (1003336140) is active in the NPPES registry as of the last update on 2024-07-11.

IndividualActiveAccepts Medicare

Kimberly Tamargo, MD

NPI 1003336140 · Dermatology Physician · Fairlawn, OH

Kimberly Tamargo, MD is a Dermatology Physician provider in Fairlawn, OH (NPI 1003336140).

Provider details

NPI number: 1003336140
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Female
Sole proprietor: No
License: 35.141401 (OH)

Practice location

3624 W Market St Ste 101

Fairlawn, OH 44333-4510

Phone: (330) 665-0555

Street-level locationGet directions

More OH providers

Mailing address

3624 W Market St Ste 101

Fairlawn, OH 44333-4510

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 35.141401 (OH)
Allopathic & Osteopathic Physicians

Additional practice locations (2)

5915 Landerbrook Dr Ste 120
Mayfield Hts, OH 44124-4034
Phone: (216) 382-3806
1560 Corporate Woods Pkwy
Uniontown, OH 44685-8730
Phone: (330) 665-0555

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(73/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
9 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
3 documented practice locations
Medicare service volume (vs. specialty peers)25% of score
3,281 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	930	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	560	$86
Destruction of Precancer Skin Growth, 1 Growth17000	441	$45
Biopsy of Related Skin Growth, First Growth11102	420	$84
Biopsy of Related Skin Growth, Each Additional Growth11103	210	$46
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 23 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	264	142
Mupirocin	243	212
Triamcinolone Acetonide	112	85
Doxycycline Monohydrate	84	69
Clobetasol Propionate	84	52
Fluorouracil	67	59
Desonide	64	47
Clindamycin Phosphate	61	38

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$2,482 across 126 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2017-06-20
Last updated: 2024-07-11
Certified: 2024-07-11

Frequently asked questions

What is Kimberly Tamargo's NPI number?: Kimberly Tamargo's National Provider Identifier (NPI) is 1003336140, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Kimberly Tamargo's specialty?: Kimberly Tamargo is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Kimberly Tamargo located?: Kimberly Tamargo's practice location on file with NPPES is 3624 W Market St Ste 101, Fairlawn, OH 44333-4510.
What is Kimberly Tamargo's phone number?: The practice phone number listed in the NPPES registry for Kimberly Tamargo is (330) 665-0555.
Does Kimberly Tamargo accept Medicare?: Kimberly Tamargo is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Kimberly Tamargo's NPI active?: Yes — Kimberly Tamargo's NPI (1003336140) is active in the NPPES registry as of the last update on 2024-07-11.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	930	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	560	$86
Destruction of Precancer Skin Growth, 1 Growth17000	441	$45
Biopsy of Related Skin Growth, First Growth11102	420	$84
Biopsy of Related Skin Growth, Each Additional Growth11103	210	$46
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More

Drug

Part D claims (2024)

Beneficiaries

Ketoconazole

264

142

Mupirocin

243

212

Triamcinolone Acetonide

112

Doxycycline Monohydrate

Clobetasol Propionate

Fluorouracil

Desonide

Clindamycin Phosphate

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$2,482 across 126 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Additional practice locations (2)

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Additional practice locations (2)

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments